Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm
In 1963, Robert Guthrie's pioneering work developing a bacterial inhibition assay to measure phenylalanine in dried blood spots, provided the means for whole-population screening to detect phenylketonuria in the USA. In the following decades, NBS became firmly established as a part of public he...
Saved in:
Main Authors: | Giancarlo la Marca (Author), Rachel. S. Carling (Author), Stuart. J. Moat (Author), Raquel Yahyaoui (Author), Enzo Ranieri (Author), James. R. Bonham (Author), Peter. C. J. I. Schielen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Dried Blood Spot Specimens to Monitor Patients with Inherited Metabolic Disorders
by: Stuart J. Moat, et al.
Published: (2020) -
Towards Achieving Equity and Innovation in Newborn Screening across Europe
by: Jaka Sikonja, et al.
Published: (2022) -
Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
by: Michael H. Gelb, et al.
Published: (2018) -
Evaluation of a Common Internal Standard Material to Reduce Inter-Laboratory Variation and Ensure the Quality, Safety and Efficacy of Expanded Newborn Screening Results When Using Flow Injection Analysis Tandem Mass Spectrometry with Internal Calibration
by: Rachel S. Carling, et al.
Published: (2020) -
First, do no harm: The patient's experience of avoidable suffering as harm
by: Ashley Bauer
Published: (2018)